On the stock market since 2014, it operates in the world of health and science. It has 115 employees. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
If every debt were paid off today, $302.8M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 5 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades 46% below its peak. The market has trimmed its expectations for the company.
There is $305.5M in the vault; even if every debt were paid off, $302.8M would remain.
The average analyst price target is $76.50 — 44% above today’s price.
The company’s market value is 132 times its annual profit. Even a small disappointment could hit the price hard.
Over the last 12 months, executives reported 85 sells against just 23 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, SLNO sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: SLNO is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.